FDA Approves Moxidectin for the Treatment of River Blindness
MELBOURNE, GENEVA, and NEW YORK - June 13, 2018 -- Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Blindness | Drugs & Pharmacology | Opthalmology | River Blindness | Training | Universities & Medical Training | USA Health | WHO